Literature DB >> 22300040

A new "era" for the α7-nAChR.

Patrizia Russo1, Alessio Cardinale, Hildegard Shuller.   

Abstract

The α7-nAChR plays critical roles in numerous organs and cells by regulating highly organ and cell typespecific functions. In this special issue different Authors have contributed to clarify the different roles played by the α7- nAChR. Post-translational processes such as receptor "underactivation" or "overactivation" are associated in the central nervous system with brain disorders including neurodegeneration, while also contributing to the regulation of nonneuronal cells and cancers derived from them. Current advances in the knowledge of α7-nAChR biology encourage the exploitation of this receptor as a therapeutic target for a variety of diseases, including Alzheimer's, disease, Parkinson's disease, cognitive decline, pain and cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22300040     DOI: 10.2174/138945012800398946

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  5 in total

1.  α7-Nicotinic Acetylcholine Receptor Promotes Cholangiocarcinoma Progression and Epithelial-Mesenchymal Transition Process.

Authors:  Shuhai Chen; Xiaoliang Kang; Guangwei Liu; Bingyuan Zhang; Xiao Hu; Yujie Feng
Journal:  Dig Dis Sci       Date:  2019-04-04       Impact factor: 3.199

2.  Burn Injury Alters Epidermal Cholinergic Mediators and Increases HMGB1 and Caspase 3 in Autologous Donor Skin and Burn Margin.

Authors:  Casey J Holmes; Jennifer K Plichta; Richard L Gamelli; Katherine A Radek
Journal:  Shock       Date:  2017-02       Impact factor: 3.454

Review 3.  Muscarinic Receptors Associated with Cancer.

Authors:  Gloria M Calaf; Leodan A Crispin; Juan P Muñoz; Francisco Aguayo; Tammy C Bleak
Journal:  Cancers (Basel)       Date:  2022-05-07       Impact factor: 6.575

4.  Studies on the role of alpha 7 nicotinic acetylcholine receptors in K562 cell proliferation and signaling.

Authors:  Gözde Önder Narin; Banu Aydın; Hülya Cabadak
Journal:  Mol Biol Rep       Date:  2021-06-18       Impact factor: 2.316

Review 5.  Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors.

Authors:  Roger L Papke; Nicole A Horenstein
Journal:  Pharmacol Rev       Date:  2021-07       Impact factor: 18.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.